Company profile: Micropharma
1.1 - Company Overview
Company description
- Provider of biotherapeutics, diagnostics, and devices for metabolic diseases, discovering and developing bacteria-based biotherapeutics and novel probiotic and enzymatic solutions through a unique approach from basic research to product development.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Micropharma
Venatorx Pharmaceuticals
HQ: United States
Website
- Description: Provider of anti-infective therapies for multi-drug-resistant bacterial and viral infections, including cefepime-taniborbactam for complicated urinary tract infections and potentially hospital-acquired and ventilator-associated bacterial pneumonia; ceftibuten-ledaborbactam etzadroxil for drug-resistant Enterobacterales; and a PBP inhibitor program developing non-beta-lactam molecules.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Venatorx Pharmaceuticals company profile →
Rempex Pharmaceuticals
HQ: United States
Website
- Description: Provider of new antibacterial drugs through discovery and development to meet clinical needs created by multi-drug resistant bacterial pathogens; San Diego-based, with an internal pipeline combining proprietary formulations and PK/PD strategies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rempex Pharmaceuticals company profile →
HandyLab
HQ: United States
Website
- Description: Provider of medical technology developing and manufacturing molecular diagnostic assays and automation platforms. Using patented real-time microfluidic PCR technology, its proprietary platform reduces the time, cost, and complexity of testing while improving result quality, and is positioned to decentralize.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HandyLab company profile →
Verax Biomedical
HQ: United States
Website
- Description: Provider of rapid tests for detecting bacterial contamination in cellular components for transfusion or transplant, including FDA-cleared Platelet PGD and PGDprime tests (now detecting Acinetobacter) and 7 Day Platelet Dating with PGD enabling 7-day platelet dating to improve platelet safety and availability while reducing costs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Verax Biomedical company profile →
Micronics
HQ: United States
Website
- Description: Provider of near-patient in vitro diagnostic products for disease diagnosis, prognosis, and treatment monitoring in the United States and internationally, including the PanNAT molecular diagnostic system, a point-of-care testing instrument.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Micronics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Micropharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Micropharma
2.2 - Growth funds investing in similar companies to Micropharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Micropharma
4.2 - Public trading comparable groups for Micropharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →